FMCG major Hindustan Unilever Ltd (HUL) and healthcare firm GSK have mutually decided to terminate their agreement for selling of Over-the-Counter (OTC) and oral care products. The agreement was ...

In 2018, HUL announced the merger ... of a sales and distribution agreement with GSK Consumer to sell the latter’s over-the-counter and oral care products such as Sensodyne, Crocin, Otrivin ...

The biggest implications of this outcome are: Firstly, this is an acknowledgment by both GSK and HUL of the huge market potential for health and health-related products worldwide. Secondly ...

The merger of GSK CH India with HUL will be on the basis of an exchange ... GSK CH India's over-the-counter and oral health products in India.

"That will depend on HUL 's merger plans ... so there is bound to be duplication of workforces. The above products are made in India by GSK Asia, which retains their functions like marketing ...

As a part of the deal, HUL has also entered into a five-year contract for the distribution business of GSK Pharmaceuticals that has over-the-counter (OTC) products such as Sensodyne, Otrivin ...

HUL has said that it will increase rural penetration for GSK brands with affordable packs and availability of products and also has plans to grow premium segment portfolio of Horlicks cardio and ...

The merger with HUL values the total business of GSK Consumer Healthcare at ₹ 31,700 ... a distribution arrangement for the rest of the products that are not being sold. On all the three ...

"Once we get the court's approval, GSK Consumer India ... with 4.39 shares of HUL being allotted for every share in GSKCH India, which sells consumer healthcare products, including popular drink ...